Clin2
NCT05370820Possibly a fitRecruiting

Tranexamic acid to prevent heavy bleeding after C-section

Post Partum Hemorrhage

Treatments studied

Part of Women’s health & pregnancy clinical trials.

This trial studies whether tranexamic acid, a medicine that helps blood clot, can prevent postpartum hemorrhage (heavy bleeding after delivery) in people having a planned C-section or likely vaginal delivery after 34 weeks. It may help lower the risk of dangerous bleeding around the time of birth.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
120 people
Ages
18 years to 50 years
Study type
Interventional

Who can take part

  • You are pregnant and plan a medically needed C-section after 34 weeks, or an elective C-section at 39 weeks
  • Or you are expected to deliver vaginally after 34 weeks
  • Your kidney function blood test is normal (creatinine under 0.9 within 2 weeks of your delivery date)
  • You are age 18 to 50
  • You can understand the study and sign consent forms

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07002749Not yet recruiting· Phase 1
Tranexamic acid to prevent heavy bleeding after planned C-section

This trial tests whether giving a medicine called tranexamic acid before a planned C-section can help prevent dangerous heavy bleeding after birth. It is for pregnant women with low-risk pregnancies who are scheduled for a planned C-section.

Karachi, Sindh
NCT06604325Recruiting
Tranexamic acid to reduce blood loss during c-section

This trial tests whether giving a medicine called tranexamic acid before a cesarean section (c-section) can help reduce the amount of blood loss during the surgery. It may be an option for women having either a planned or unplanned c-section.

Fatehpur, Uttar Pradesh
NCT06010368Not yet recruiting· Phase 3
Comparing two drugs to reduce bleeding during planned c-section

This study compares two medications (tranexamic acid and oxytocin) given directly into the uterus during a planned cesarean section to see which works better at reducing blood loss. It is for women with a single, full-term pregnancy and no major health complications.

Ismailia
NCT07318467Not yet recruiting
Comparing medicine combinations to prevent heavy bleeding after c-section

This trial tests whether giving a specific combination of three medicines during a planned c-section is better than one medicine alone for preventing postpartum hemorrhage (heavy bleeding after birth).

NCT04304625Recruiting· Phase 3
Tranexamic acid to reduce blood loss after C-section

This trial studies whether tranexamic acid can prevent heavy bleeding after a planned or urgent cesarean delivery in people with placenta previa. If you qualify, you may receive the study drug to help your body keep blood loss lower during and after surgery.

Bordeaux
NCT07390799Not yet recruiting
Tranexamic acid to prevent bleeding in repeat c-section

This trial is for women having their second or third planned c-section. It tests if giving a medicine called tranexamic acid helps prevent heavy bleeding. The medicine is safe and commonly used to reduce bleeding.

Izmir, Menemen

Hear when a new Post Partum Hemorrhage trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.